Professor, Department of Pancreatic & Hepatobiliary Surgery
Fudan University, China
Dr. Xianjun Yu got his MD from Fudan University, Shanghai, China in 1994 and his PhD from Fudan University in 2003. He started his career in pancreatic cancer research as an Associate Professor since 2004. Currently Dr. Yu is Professor and Chair of the Department of Pancreatic & Hepatobiliary Surgery, Shanghai Cancer Center, Fudan University since 2010. He is the Vice President of Pancreatic Disease Institute of Fudan University and Secretary of Chinese Association for Anti-Pancreatic Cancer Committee since 2010. Dr. Yu′s major goal is to develop a new therapy for pancreatic cancer and deliver the best care to the patients with pancreatic cancer through the basic and clinical research. Dr. Yu′s group is the first one to use LyP-1 peptide as a molecular target for specific drug delivery to lymphatic metastatic pancreatic cancer. He has published more than 20 papers and serves as an editorial board member of many journals.